Nilotinib for Cytomegalovirus Prophylaxis and Treatment After Allogeneic Hematopoietic Stem Cell Transplantation

Clinical trial NCT01252017 · COMPLETED

Trial details

NCT number: NCT01252017
Sponsor: National Taiwan University Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Patients Who Have Received Allo-HSCT

Start date: 2010-11-01
Primary completion: 2013-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.